News
-
-
PRESS RELEASE
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Zurich Kantonalbank and subsidiaries disclose a 1.06% interest in Cicor Technologies Ltd. through 48,328 securities. Transactions made on 8th Dec 2025 include sales at CHF 184.125 and CHF 184.0455 per unit and purchases at CHF 182.5 per unit -
-
-
-
-
-
-
-
PRESS RELEASE
BioNxt Advances "Melt in Your Mouth" Cladribine Formulation to Improve Treatment for MS Patients with Dysphagia
BioNxt Solutions Inc. is developing a sublingual cladribine ODF to enhance MS treatment access. The innovative technology aims to improve swallowing difficulties and increase therapy adherence